455 related articles for article (PubMed ID: 10878819)
61. Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease.
Maraganore DM; Farrer MJ; Lesnick TG; de Andrade M; Bower JH; Hernandez D; Hardy JA; Rocca WA
Mov Disord; 2003 Nov; 18(11):1233-9. PubMed ID: 14639662
[TBL] [Abstract][Full Text] [Related]
62. Convergent pathobiologic model of Parkinson's disease.
Maguire-Zeiss KA; Federoff HJ
Ann N Y Acad Sci; 2003 Jun; 991():152-66. PubMed ID: 12846984
[TBL] [Abstract][Full Text] [Related]
63. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
Hague SM; Klaffke S; Bandmann O
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1058-63. PubMed ID: 16024878
[TBL] [Abstract][Full Text] [Related]
64. Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
Rajagopalan S; Andersen JK
Mech Ageing Dev; 2001 Sep; 122(14):1499-510. PubMed ID: 11511392
[TBL] [Abstract][Full Text] [Related]
65. Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms.
Bonifati V; Oostra BA; Heutink P
Cell Mol Life Sci; 2004 Jul; 61(14):1729-50. PubMed ID: 15241550
[TBL] [Abstract][Full Text] [Related]
66. Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity.
Volles MJ; Lansbury PT
J Mol Biol; 2007 Mar; 366(5):1510-22. PubMed ID: 17222866
[TBL] [Abstract][Full Text] [Related]
67. [Studies on pathogenesis of Parkinson's disease].
Mizuno Y
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():66-70. PubMed ID: 15796059
[No Abstract] [Full Text] [Related]
68. Alpha-synuclein: between synaptic function and dysfunction.
Di Rosa G; Puzzo D; Sant'Angelo A; Trinchese F; Arancio O
Histol Histopathol; 2003 Oct; 18(4):1257-66. PubMed ID: 12973692
[TBL] [Abstract][Full Text] [Related]
69. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis.
Krishnan S; Chi EY; Wood SJ; Kendrick BS; Li C; Garzon-Rodriguez W; Wypych J; Randolph TW; Narhi LO; Biere AL; Citron M; Carpenter JF
Biochemistry; 2003 Jan; 42(3):829-37. PubMed ID: 12534296
[TBL] [Abstract][Full Text] [Related]
70. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.
Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F
Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179
[TBL] [Abstract][Full Text] [Related]
71. Chasing genes in Alzheimer's and Parkinson's disease.
Bertoli-Avella AM; Oostra BA; Heutink P
Hum Genet; 2004 Apr; 114(5):413-38. PubMed ID: 14999561
[TBL] [Abstract][Full Text] [Related]
72. The genetics of Parkinson's disease.
Lim KL; Dawson VL; Dawson TM
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):439-46. PubMed ID: 12169225
[TBL] [Abstract][Full Text] [Related]
73. Analysis of the alpha-synuclein G209A mutation in familial Parkinson's disease.
Zareparsi S; Kaye J; Camicioli R; Kramer P; Nutt J; Bird T; Litt M; Payami H
Lancet; 1998 Jan; 351(9095):37-8. PubMed ID: 9433434
[No Abstract] [Full Text] [Related]
74. Regulation of alpha-synuclein expression: implications for Parkinson's disease.
Chiba-Falek O; Nussbaum RL
Cold Spring Harb Symp Quant Biol; 2003; 68():409-15. PubMed ID: 15338643
[No Abstract] [Full Text] [Related]
75. Parkinson's disease: alpha-synuclein build-up explained.
Burton A
Lancet Neurol; 2004 Oct; 3(10):575. PubMed ID: 15461988
[No Abstract] [Full Text] [Related]
76. New movement in Parkinson's.
Lozano AM; Kalia SK
Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304
[No Abstract] [Full Text] [Related]
77. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses.
Trojanowski JQ; Lee VM
Neurotoxicology; 2002 Oct; 23(4-5):457-60. PubMed ID: 12428717
[TBL] [Abstract][Full Text] [Related]
78. Neuroscientists put gene therapy into reverse.
Giles J
Nature; 2005 Nov; 438(7067):402-3. PubMed ID: 16306948
[No Abstract] [Full Text] [Related]
79. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease.
Whitworth AJ; Wes PD; Pallanck LJ
Drug Discov Today; 2006 Feb; 11(3-4):119-26. PubMed ID: 16533709
[TBL] [Abstract][Full Text] [Related]
80. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.
Burbulla LF; Krüger R
J Neurol Sci; 2011 Jul; 306(1-2):1-8. PubMed ID: 21513949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
